liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Polymorphism of the p38 beta gene in patients with colorectal cancer
University of Coll Health Science, Sweden .
Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för läkemedelsforskning. Linköpings universitet, Hälsouniversitetet.
Ryhov County Hospital, Sweden .
Ryhov County Hospital, Sweden .
Visa övriga samt affilieringar
2014 (Engelska)Ingår i: Oncology Letters, ISSN 1792-1074, E-ISSN 1792-1082, Vol. 8, nr 3, s. 1093-1095Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The p38 mitogen-activated protein kinase (MAPK) signaling pathways have been proposed to participate in the pathological process of cancer by affecting inflammation, proliferation, metastasis and cell survival. A single nucleotide polymorphism (SNP; rs2235356, -1628A -greater than G) in the promoter region of the p38 beta gene has been proposed as a genetic modifier for colorectal cancer (CRC) in a Chinese population. The present study evaluated the susceptibility of patients possessing this SNP to CRC, in addition to determining its association with clinical parameters in Swedish patients with CRC. Using the LightSNiP genotyping assay, this SNP was screened in 389 patients with CRC and 517 control subjects. No significant difference in the genotype distribution or in the allelic frequencies was identified between the two groups nor was any association identified with the clinical parameters. These findings indicate that the -1628A -greater than G polymorphism of the p38 beta gene is not significantly associated with a susceptibility to CRC in a Swedish population.

Ort, förlag, år, upplaga, sidor
Spandidos Publications , 2014. Vol. 8, nr 3, s. 1093-1095
Nyckelord [en]
p38 beta; promoter region; single nucleotide polymorphism; colorectal cancer
Nationell ämneskategori
Klinisk medicin
Identifikatorer
URN: urn:nbn:se:liu:diva-110697DOI: 10.3892/ol.2014.2315ISI: 000340854600024PubMedID: 25120664OAI: oai:DiVA.org:liu-110697DiVA, id: diva2:749244
Anmärkning

Funding Agencies|Futurum; Academy for Healthcare; County Council (Jonkoping, Sweden) [105891]; Foundation of Clinical Cancer Research (Jonkoping, Sweden) [110426-1]; University College of Health Sciences (Jonkoping, Sweden)

Tillgänglig från: 2014-09-23 Skapad: 2014-09-19 Senast uppdaterad: 2017-12-05

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Slind Olsen, Renate

Sök vidare i DiVA

Av författaren/redaktören
Slind Olsen, Renate
Av organisationen
Avdelningen för läkemedelsforskningHälsouniversitetet
I samma tidskrift
Oncology Letters
Klinisk medicin

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 135 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf